|
HNRNPUL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.740400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.861800E-01 |
| Normal-vs-Stage2 |
4.336100E-02 |
| Normal-vs-Stage3 |
7.408300E-04 |
| Normal-vs-Stage4 |
4.323800E-03 |
| Stage1-vs-Stage2 |
1.639890E-02 |
| Stage1-vs-Stage3 |
3.55410000000278E-05 |
| Stage1-vs-Stage4 |
8.212100E-04 |
| Stage2-vs-Stage3 |
5.131000E-01 |
| Stage2-vs-Stage4 |
7.214000E-01 |
| Stage3-vs-Stage4 |
7.262400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.141700E-02 |
| Normal-vs-AfricanAmerican |
3.128400E-01 |
| Normal-vs-Asian |
8.139800E-01 |
| Caucasian-vs-AfricanAmerican |
8.835800E-01 |
| Caucasian-vs-Asian |
8.208200E-01 |
| AfricanAmerican-vs-Asian |
8.932200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.892430E-02 |
| Normal-vs-Female |
4.554200E-01 |
| Male-vs-Female |
6.907700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.064800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.990800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.204200E-02 |
| Normal-vs-Age(81-100Yrs) |
8.893700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.550600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.811000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.894800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.846350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.360350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.067600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.475260E-03 |
| Normal-vs-Grade 2 |
7.202400E-01 |
| Normal-vs-Grade 3 |
9.460400E-03 |
| Normal-vs-Grade 4 |
5.790400E-04 |
| Grade 1-vs-Grade 2 |
4.377700E-03 |
| Grade 1-vs-Grade 3 |
1.808980E-04 |
| Grade 1-vs-Grade 4 |
3.07649999997661E-06 |
| Grade 2-vs-Grade 3 |
6.555900E-03 |
| Grade 2-vs-Grade 4 |
5.982700E-04 |
| Grade 3-vs-Grade 4 |
1.605620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.196200E-01 |
| Normal-vs-ccB subtype |
1.035880E-04 |
| ccA subtype-vs-ccB subtype |
7.26329996147967E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.467800E-02 |
| Normal-vs-N1 |
7.737300E-03 |
| N0-vs-N1 |
1.700560E-01 |
|
|
